Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FDP | Ordinary Shares | Purchase | $236K | +10K | +0.31% | $23.62 | 3.26M | Feb 28, 2024 | Direct | F1 |
transaction | FDP | Ordinary Shares | Purchase | $76.8K | +3.25K | +0.1% | $23.63 | 3.27M | Feb 29, 2024 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | FDP | Dividend Equivalent Units | 136 | Feb 28, 2024 | Ordinary Shares | 136 | Direct | F3 | ||||||
holding | FDP | Restricted Stock Units | 5.67K | Feb 28, 2024 | Ordinary Shares | 5.67K | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $23.27 to $23.65 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
F2 | Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $23.53 to $23.65 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
F3 | Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting and/or performance criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. |
F4 | The RSUs convert to Ordinary Shares on a one-for-one basis. |
F5 | These RSUs shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 4, 2023); and (ii) the date of the next annual meeting of the shareholders of the Issuer that follows the grant date. |